| Prev Close | 76.19 |
| Day Low/High | 72.51 / 77.69 |
| 52 Wk Low/High | 75.06 / 308.00 |
Teladoc Health, Inc. (TDOC)
72.90
NYSE
| Exchange | NYSE |
| Shares Outstanding | 160.09B |
| Market Cap | 12.20B |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
More Big Deals for Health Care Eyed in 2022
As M&A investments could hit $400 billion this year, watch for buys in health technology and data, biotech, pharma and medical devices.
I'm Treading Carefully Entering 2022 as Many Momentum Stocks Remain Bearish
Cannabis is about the only space where I'm long, and that isn't for technical reasons.
Are Record ETF Inflows a Red Flag for Investors?
There's an expectation that ETF investors increase bullishness and inflows around peaks.
Evergrande, Markets, Omicron, The Week Ahead, Salesforce, Advanced Micro Devices
I think I'm likely to remain 'skinny' for now, and prioritize trading over investment at least for the next 10 business days or so.
Play With Fire? You Might Get Burned
Money-losing companies, even those who have potentially good prospects, are becoming less valuable on an absolute basis by the amount of their losses.
One Stock to Buy and Two to Avoid as Omicron Variant Plays
Homebuilder Toll Brothers is sporting an appealing chart, while Teledoc Health and Peloton Interactive remain names to steer clear of at present.
Are Recent Negative Returns Reason Enough to Reassess Cathie Wood and ARK?
Recent poor performance has many doubters piping up on the star stock-picker.
Investors Aren't Leaving Cathie Wood in the Dust Just Yet
The ARK funds are seeing some investor mutiny, but many say they still believe in Wood, her stock picks and her investing philosophy.
This Feels Like More Than Just Summer Doldrums
Is an incredibly big earnings night the opportunity for a needed washout?
Chinese Crackdown, Bitcoin/Amazon, Tesla Earnings, My Big Plan for a Big Night
Why we ever allowed Chinese businesses to raise capital, our capital, on our shores, is beyond me.
Reopening, Reclosing Trades Nothing to Sneeze At
I'm not looking to play either as the delta variant makes for an uneasy market, but here's what I am looking at right now.
Is Solar About to Heat Up?
Indications are that it already is, with SolarEdge Technologies appearing to be the best bet of the solar bunch.
I'm Not Buying This Rally
Buy I am buying SPDR S&P 500 exchange-traded fund puts -- here's how.
Jim Cramer: Let Me Explain How Good Companies Can Have Bad Stocks
Here's a lesson I learned decades ago at Goldman Sachs about how stocks can move in times like this.
The Trade Desk: Another Unhappy Ending for Momentum Traders?
Like other momentum stocks, the provider of software to manage digital ad campaigns traded way over its skis and suddenly finds itself tumbling.
I Stopped Believing in ARKK Months Ago
* Here's why ARK Invest's holdings are impacting the Nasdaq * ARKK weakness - and the attendant sales of its largest positions - may augur poorly for the Nasdaq in the weeks ahead "Just a small town girl Livin' in a lonely world She took the midnig...
5 Takeaways From an Eventful Tech Earnings Season
Among other things, results revealed that quite a few firms are now facing a higher bar, and that reopenings have begun affecting consumer behavior in a number of ways.
The Doctor Is in, Teladoc Is Out
Roll up your sleeve and know this might hurt a bit: The charts of TDOC show prices are pointed ... lower.
I Gotta Tell Ya...
Watch and some of its constituent positions - , , , , etc. Not good. My short thesis on the name seems ever more compelling - with the nail on the ARK Invest perhaps an exodus of investors as outflows begin to rise/mount.   Â
Earnings Avalanche, FOMC, Growth and Inflation, Biden's Spending Plans
The US Ten Year Note has been on the move, and the US Dollar Index has also been climbing overnight.
Here's My Reply to a Subscriber Who Asked About the ARK Innovation ETF
ARKK has produced impressive gains but it looks like it is still in a correction phase. Here's what aggressive traders could do.
The Doctor Found Something Amiss on the Charts of Teladoc
The name appears bearish and risky right now.
Are ViacomCBS and Discovery Worth a Look After Their Big Slides?
The answer is yes for one of the two stocks that sold off sharply due to forced liquidations by a big shareholder.
Jim Cramer: The Do's and Don'ts to Survive This Market
You need to respect that a market can be as vicious and nasty as it was joyous and oblivious toward the news that comes its way.
Here's Why I'm Selling Teladoc Health
Volume has picked up dramatically since a selloff in the online health services provider began, and it could get worse.
Hall of Mirrors, Connecting the Fed Dots, National Debt Q&A, Amazon Disrupts
As a very wise man once said: 'I'll gladly pay you Tuesday for a hamburger today.'
I Like the Growth Prospects for TeleHealth Stock LifeMD
Since we don't have a breakout, I would stay with a half-size approach on any trade here.
